APA (7th ed.) Citation

Acevedo-Ramos, A., Zuluaga-Liberato, A., & Díaz-Casas, S. E. (2025). Oncologic Outcomes and Safety of Neoadjuvant Treatment with Anthracyclines Versus Anthracycline-Free Regimens in HER2-Positive Early Breast Cancer in a Colombian Cancer Center: An Observational, Analytical, Retrospective Study. Cancers, 17(19), 3190. https://doi.org/10.3390/cancers17193190

Chicago Style (17th ed.) Citation

Acevedo-Ramos, Alfredo, Andrea Zuluaga-Liberato, and Sandra E. Díaz-Casas. "Oncologic Outcomes and Safety of Neoadjuvant Treatment with Anthracyclines Versus Anthracycline-Free Regimens in HER2-Positive Early Breast Cancer in a Colombian Cancer Center: An Observational, Analytical, Retrospective Study." Cancers 17, no. 19 (2025): 3190. https://doi.org/10.3390/cancers17193190.

MLA (9th ed.) Citation

Acevedo-Ramos, Alfredo, et al. "Oncologic Outcomes and Safety of Neoadjuvant Treatment with Anthracyclines Versus Anthracycline-Free Regimens in HER2-Positive Early Breast Cancer in a Colombian Cancer Center: An Observational, Analytical, Retrospective Study." Cancers, vol. 17, no. 19, 2025, p. 3190, https://doi.org/10.3390/cancers17193190.